Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

Bachem是一家領(lǐng)先的創(chuàng)新驅(qū)動型公司，專門從事肽和寡核苷酸的開發(fā)和制造。該公司擁有50多年的經(jīng)驗和專業(yè)知識，為全球制藥和生物技術(shù)公司提供研究、臨床開發(fā)和商業(yè)應(yīng)用產(chǎn)品，并提供全面的服務(wù)。Bachem在國際上運營，總部位于瑞士，在歐洲、美國和亞洲設(shè)有辦事處。該公司在瑞士六大交易所上市。